Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia

NU COVID Investigators

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Rationale: Current guidelines recommend patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia receive empirical antibiotics for suspected bacterial superinfection on the basis of weak evidence. Rates of ventilatorassociated pneumonia (VAP) in clinical trials of patients with SARS-CoV-2 pneumonia are unexpectedly low. Objectives: We conducted an observational single-center study to determine the prevalence and etiology of bacterial superinfection at the time of initial intubation and the incidence and etiology of subsequent bacterial VAP in patients with severe SARS-CoV-2 pneumonia. Methods: Bronchoscopic BAL fluid samples fromall patients with SARS-CoV-2 pneumonia requiringmechanical ventilation were analyzed using quantitative cultures and amultiplex PCR panel. Actual antibiotic use was compared with guideline-recommended therapy. Measurements and Main Results: We analyzed 386 BAL samples from 179 patients with SARS-CoV-2 pneumonia requiring mechanical ventilation. Bacterial superinfection within 48 hours of intubation was detected in 21% of patients. Seventy-two patients (44.4%) developed at least one VAP episode (VAP incidence rate = 45.2/1,000 ventilator days); 15 (20.8%) initial VAPs were caused by difficult-to-treat pathogens. The clinical criteria did not distinguish between patients with or without bacterial superinfection. BALbased management was associated with significantly reduced antibiotic use compared with guideline recommendations. Conclusions: In patients with SARS-CoV-2 pneumonia requiring mechanical ventilation, bacterial superinfection at the time of intubation occurs in <25% of patients. Guideline-based empirical antibiotic management at the time of intubation results in antibiotic overuse. Bacterial VAP developed in 44% of patients and could not be accurately identified in the absence of microbiologic analysis of BAL fluid.

Original languageEnglish (US)
Pages (from-to)921-932
Number of pages12
JournalAmerican journal of respiratory and critical care medicine
Volume204
Issue number8
DOIs
StatePublished - Oct 15 2021

Keywords

  • Bronchoalveolar lavage
  • COVID-19
  • Community-acquired pneumonia
  • Guideline therapy
  • Ventilator-associated pneumonia

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia'. Together they form a unique fingerprint.

Cite this